We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 79

Generic Health succeeds in invalidating patent for aripiprazole: Otsuka Pharmaceutical Co., Ltd v Generic Health Pty Ltd (No 4) 2015 FCA 634
  • King & Wood Mallesons
  • Australia
  • July 7 2015

Generic Health is perhaps a step closer to bringing its generic version of the antipsychotic drug aripiprazole to market in Australia after Justice


FWC supports employer’s right to nominate doctor
  • King & Wood Mallesons
  • Australia
  • July 8 2014

The Fair Work Commission has ruled that an employer was entitled to require one of its employees to attend an appointment with a general practitioner


Blockbuster drug goes bust? The Federal Court finds three AstraZeneca patents relating to Crestor (rosuvastatin) invalid
  • King & Wood Mallesons
  • Australia
  • March 7 2013

In an important decision handed down on Tuesday, Justice Jagot of the Federal Court held that three patents relating to the blockbuster drug Crestor


Otsuka successful in stay application: Otsuka Pharmaceutical Co., Ltd v Generic Health Pty Ltd 2015 FCA 848
  • King & Wood Mallesons
  • Australia
  • August 26 2015

Further to our post of 7 July 2015, the proceedings brought by Otsuka and Bristol Myers Squibb (the "exclusive licensee" of Otsuka's patents for


High Court re-invents the test for patentable subject matter and finds the patent for the isolated breast cancer gene invalid
  • King & Wood Mallesons
  • Australia
  • October 8 2015

The High Court has handed down a significant decision finding that patent claims for isolated gene sequences, indicative of a predisposition to


Australian case notes - Odisho v Bonazzi 2014 VSCA 11
  • King & Wood Mallesons
  • Australia
  • May 20 2014

In this case the appellant, a patient who suffered a thromboembolic event following the use of tranexamic acid, claimed that her doctor had


Food law: quick bites and upcoming calendar
  • King & Wood Mallesons
  • Australia
  • April 30 2015

The ACCC is seeking leave to appeal the Federal Court decision dismissing its case against Pfizer for alleged misuse of market power and exclusive


High Court grants special leave to appeal extension of time in pharmaceutical patent case
  • King & Wood Mallesons
  • Australia
  • April 15 2014

Last Friday the High Court of Australia granted Alphapharm special leave to appeal from a decision of the Full Federal Court in Aspen Pharma Pty Ltd


Homeopathy plus! Not immune from the ACL
  • King & Wood Mallesons
  • Australia
  • March 7 2013

On 21 February 2013, the ACCC instituted proceedings against Homeopathy Plus! Australia Pty Ltd ("Homeopathy Plus!") in the Federal Court of


Vision Eye Institute Ltd v Kitchen (no 2) 2015 QSC 66
  • King & Wood Mallesons
  • Australia
  • July 2 2015

In this case, the Queensland Supreme Court awarded a significant amount of damages for contingent loss of income flowing from a breach of contract